PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients.
(Q44846498)
scientific article published in September 2006
scientific article published in September 2006
Language:
Current Data About
PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients.
other details
description | scientific article published in September 2006 |
External Links
(P356) |
10.1016/S1556-0864(15)30374-9
|
(P698) |
17409929
|